⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25258 | 1.00 | — | — | |
| SCHEMBL2855447 | 1.00 | — | — | |
| SCHEMBL29134148 | 0.97 | — | — | |
| SCHEMBL27268805 | 0.97 | — | — | |
| SCHEMBL27959934 | 0.97 | — | — | |
| SCHEMBL23069495 | 0.90 | — | — | |
| SCHEMBL26549 | 0.90 | — | — | |
| SCHEMBL8081847 | 0.90 | — | — | |
| SCHEMBL11162195 | 0.89 | LMNA (0.43) | — | |
| SCHEMBL1972553 | 0.89 | LMNA (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0227306-B1 | PEPTIDE IMMUNOSTIMULANTS | PFIZER INC. (US) | 1989-09-13 | — | — | EP | claimed |
| US-4767743-A | ANTIINFECTION AGENTS | PFIZER INC. (US) | 1988-08-30 | — | — | US | claimed |
| EP-0227306-A2 | Peptide immunostimulants | PFIZER INC. (US) | 1987-07-01 | — | — | EP | claimed |
| EP-3464296-B1 | ISOTHIAZOLOPYRIDONES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS | BAYER CROPSCIENCE AG (DE) | 2020-10-14 | — | — | EP | disclosed |
| US-20200317690-A1 | NOVEL ISOTHIAZOLOPYRIDONES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND/OR PLANT GROWTH REGULATORS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-10-08 | — | — | US | disclosed |
| EP-1211242-B1 | PROSTAGLANDIN DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2010-01-13 | — | — | EP | disclosed |
| CN-1196678-C | Prostaglandin E1 derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2005-04-13 | — | — | CN | disclosed |
| US-6822112-B1 | PROSTAGLANDIN D2 AGONISTS; KIDNEY, CARDIOVASCULAR, AND SLEEP DISORDERS; ANTIISCHEMIC AND HYPOTENSIVE AGENTS | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-11-23 | — | — | US | disclosed |
| US-6740772-B1 | Prostaglandin derivatives | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2004-05-25 | — | — | US | disclosed |
| US-6455584-B1 | GROWTH INHIBITION OF VASCULAR SMOOTH MUSCLE; PREVENTION OR THERAPY OF THE RESTENOSIS AFTER PTCA. | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2002-09-24 | — | — | US | disclosed |
| CN-1368959-A | Prostaglandin derivatives | TAISHO PHARMACEUTICAL CO LTD (JP) | 2002-09-11 | — | — | CN | disclosed |
| EP-0699731-B1 | Optically avtive smectic photo-curable liquid crystals | ROLIC AG (CH) | 2000-10-04 | — | — | EP | disclosed |
| US-5650534-A | Optically active smectic photo-cross-linkable liquid crystals | ROLIC AG (CH) | 1997-07-22 | — | — | US | disclosed |
| CN-1126748-A | Optically active smectic photo-cross-linkable liquid crystals | HOFFMANN LA ROCHE (CH) | 1996-07-17 | — | — | CN | disclosed |
| EP-0699731-A2 | Optically avtive smectic photo-curable liquid crystals | F. HOFFMANN-LA ROCHE AG (CH) | 1996-03-06 | — | — | EP | disclosed |
| US-4980082-A | DISPLAY ELEMENTS; HIGH SPEED RESPONSE TO ELECTRICAL FIELDS | SEIKO INSTRUMENTS INC. (JP) | 1990-12-25 | — | — | US | disclosed |
| EP-0227306-B1 | PEPTIDE IMMUNOSTIMULANTS | PFIZER INC. (US) | 1989-09-13 | — | — | EP | disclosed |
| US-4767743-A | ANTIINFECTION AGENTS | PFIZER INC. (US) | 1988-08-30 | — | — | US | disclosed |
| EP-0262809-A1 | Pyrimidinylphenyl ester compound | TEIKOKU CHEMICAL INDUSTRY CO., LTD. (JP) | 1988-04-06 | — | — | EP | disclosed |
| EP-0227306-A2 | Peptide immunostimulants | PFIZER INC. (US) | 1987-07-01 | — | — | EP | disclosed |